Diabetic neuropathic pain in a leg amputated 44 years previously

被引:10
|
作者
Rajbhandari, SM
Jarratt, JA
Griffiths, PD
Ward, JD
机构
[1] Royal Hallamshire Hosp, Ctr Diabet, Sheffield S10 2JF, S Yorkshire, England
[2] Royal Hallamshire Hosp, Dept Neurol, Sheffield S10 2JF, S Yorkshire, England
[3] Royal Hallamshire Hosp, Dept Radiol, Sheffield S10 2JF, S Yorkshire, England
关键词
painful neuropathy; diabetes; phantom limb pain; neuromatrix;
D O I
10.1016/S0304-3959(99)00163-3
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The mechanism of neuropathic pain in the diabetic limb is far from clear. Phantom limb pain likewise is of obscure aetiology. The development of typical pain in an absent leg in a patient with diabetes many years after the amputation stimulates thought as to the mechanism, not only of neuropathic pain, but also of phantom limb pain. A 58-year-old man was diagnosed with type 2 diabetes 44 years after having undergone left below knee amputation for congenital AV malformation, at the age of 13. Eight months before the diagnosis of diabetes he began to complain of pain in the leg on the amputated side-pain very similar to that described in typical diabetic neuropathy. This was followed by similar pain in the right leg. MR scan of the spine revealed a small syringohydromyelia of the thoracic cord in addition to a prolapse of disc at L-5/S-1 level on the left side, which was first noted 5 years previously. There were no other features of S-1 compression. The typical neuropathic character of the pain involving both the amputated and the intact limbs that developed with the diagnosis of type 2 diabetes suggest that the neuropathic pain may originate from centres higher than peripheral nerves. (C) 1999 International Association for the Study of Pain. Published by Elsevier Science B.V.
引用
收藏
页码:627 / 629
页数:3
相关论文
共 50 条
  • [21] Anti-nociceptive effect of duloxetine in mouse model of diabetic neuropathic pain
    Kuhad, Anurag
    Bishnoi, Mahendra
    Chopra, Kanwaljit
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 2009, 47 (03) : 193 - 197
  • [22] Antihyperalgesic and antiallodynic effects of mianserin on diabetic neuropathic pain: A study on mechanism of action
    Ucel, Umut Irfan
    Can, Ozgur Devrim
    Ozkay, Umide Demir
    Ozturk, Yusuf
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 756 : 92 - 106
  • [23] Pharmacopuncture of Bauhinia variegata Nanoemulsion Formulation against Diabetic Peripheral Neuropathic Pain
    Gupta, Pushpraj S.
    Singh, Sunil K.
    Tripathi, Abhishek K.
    JOURNAL OF PHARMACOPUNCTURE, 2020, 23 (01) : 30 - 36
  • [24] Comparative effectiveness of antinociceptive gene therapies in animal models of diabetic neuropathic pain
    Wang, Y.
    Nowicki, M. O.
    Wang, X.
    Arnold, W. D.
    Fernandez, S. A.
    Mo, X.
    Wechuk, J.
    Krisky, D.
    Goss, J.
    Wolfe, D.
    Popovich, P. G.
    Lawler, S.
    Chiocca, E. A.
    GENE THERAPY, 2013, 20 (07) : 742 - 750
  • [25] Intrathecal circHIPK3 shRNA alleviates neuropathic pain in diabetic rats
    Wang, Liang
    Luo, Tianyou
    Bao, Zhihua
    Li, Yuan
    Bu, WenJin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 505 (03) : 644 - 650
  • [26] Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?
    Russell, JW
    NATURE CLINICAL PRACTICE NEUROLOGY, 2006, 2 (01): : 18 - 19
  • [27] Kynurenine, Tetrahydrobiopterin, and Cytokine Inflammatory Biomarkers in Individuals Affected by Diabetic Neuropathic Pain
    Staats Pires, Ananda
    Heng, Benjamin
    Tan, Vanessa X.
    Latini, Alexandra
    Russo, Marc A.
    Santarelli, Danielle M.
    Bailey, Dominic
    Wynne, Katie
    O'Brien, Jayden A.
    Guillemin, Gilles J.
    Austin, Paul J.
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [28] Comparative effectiveness of antinociceptive gene therapies in animal models of diabetic neuropathic pain
    Y Wang
    M O Nowicki
    X Wang
    W D Arnold
    S A Fernandez
    X Mo
    J Wechuk
    D Krisky
    J Goss
    D Wolfe
    P G Popovich
    S Lawler
    E A Chiocca
    Gene Therapy, 2013, 20 : 742 - 750
  • [29] Preclinic and clinic effectiveness of gabapentin and pregabalin for treatment of neuropathic pain in rats and diabetic patients
    Surcheva, Slavina
    Todorova, Lubina
    Maslarov, Dimitar
    Vlaskovska, Mila
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2017, 31 (03) : 568 - 573
  • [30] Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy
    Spallone, V.
    Morganti, R.
    D'Amato, C.
    Greco, C.
    Cacciotti, L.
    Marfia, G. A.
    DIABETIC MEDICINE, 2012, 29 (05) : 578 - 585